EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Insight into Mantle Cell Lymphoma Pathobiology, Diagnosis, and Treatment Using Network-Based and Drug-Repurposing Approaches

Georgia Orfanoudaki, Konstantina Psatha, Michalis Aivaliotis iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25137298 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Georgia Orfanoudaki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Functional Proteomics and Systems Biology (FunPATh), Center for Interdisciplinary Research and Innovation (CIRI-AUTH), Balkan Center, GR-54124 Thessa…. Hauptthemen laut MEDLINE: Lymphoma, Mantle-Cell, Drug Repositioning. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Advanced Research Activities in Biomedical and Agro-alimentary Technologies, Competitiveness, Entrepreneurship and Innovation, Reinforcement of Postdoctoral Researchers—2nd Cycle.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mantle cell lymphoma (MCL) is a rare, incurable, and aggressive B-cell non-Hodgkin lymphoma (NHL). Early MCL diagnosis and treatment is critical and puzzling due to inter/intra-tumoral heterogeneity and limited understanding of the underlying molecular mechanisms. We developed and applied a multifaceted analysis of selected publicly available transcriptomic data of well-defined MCL stages, integrating network-based methods for pathway enrichment analysis, co-expression module alignment, drug repurposing, and prediction of effective drug combinations. We demonstrate the “butterfly effect” emerging from a small set of initially differentially expressed genes, rapidly expanding into numerous deregulated cellular processes, signaling pathways, and core machineries as MCL becomes aggressive. We explore pathogenicity-related signaling circuits by detecting common co-expression modules in MCL stages, pointing out, among others, the role of VEGFA and SPARC proteins in MCL progression and recommend further study of precise drug combinations. Our findings highlight the benefit that can be leveraged by such an approach for better understanding pathobiology and identifying high-priority novel diagnostic and prognostic biomarkers, drug targets, and efficacious combination therapies against MCL that should be further validated for their clinical impact.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Mantle-CellDrug RepositioningHumansGene Expression Regulation, NeoplasticGene Regulatory NetworksOsteonectinVascular Endothelial Growth Factor ATranscriptomeGene Expression ProfilingBiomarkers, TumorSignal TransductionAntineoplastic Agents

Stichwörter der Autor:innen

biomarkersdifferentially expresseddrug repurposingmantle cell lymphomanon-Hodgkin lymphomastages

Substanzen

OsteonectinVascular Endothelial Growth Factor ASPARC protein, humanBiomarkers, TumorVEGFA protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Functional Proteomics and Systems Biology (FunPATh), Center for Interdisciplinary Research and Innovation (CIRI-AUTH), Balkan Center, GR-54124 Thessaloniki, Greece.
  • Institute of Molecular Biology and Biotechnology Foundation for Research and Technology-Hellas, GR-70013 Heraklion, Greece.
  • Laboratory of Medical Biology-Genetics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, GR-54124 Thessaloniki, Greece.
  • Basic and Translational Research Unit, Special Unit for Biomedical Research and Education, School of Medicine, Aristotle University of Thessaloniki, GR-54124 Thessaloniki, Greece.
  • Laboratory of Biological Chemistry, School of Medicine, Aristotle University of Thessaloniki, GR-54124 Thessaloniki, Greece.

ORCID-Profile: Michalis Aivaliotis

Förderung

  • Advanced Research Activities in Biomedical and Agro-alimentary Technologies
  • Competitiveness, Entrepreneurship and Innovation
  • Reinforcement of Postdoctoral Researchers—2nd Cycle

Zitieren

APA

Orfanoudaki, G., Psatha, K., & Aivaliotis, M. (2024). Insight into Mantle Cell Lymphoma Pathobiology, Diagnosis, and Treatment Using Network-Based and Drug-Repurposing Approaches. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137298

Vancouver

Orfanoudaki G, Psatha K, Aivaliotis M. Insight into Mantle Cell Lymphoma Pathobiology, Diagnosis, and Treatment Using Network-Based and Drug-Repurposing Approaches. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137298

BibTeX
@article{Orfanoudaki2024,
  author = {Orfanoudaki, Georgia and Psatha, Konstantina and Aivaliotis, Michalis},
  title = {Insight into Mantle Cell Lymphoma Pathobiology, Diagnosis, and Treatment Using Network-Based and Drug-Repurposing Approaches},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25137298}
}
Kostenlos starten →